pharma · Spinal Cord Injury · Neurological; Disorder, Nervous System
UroGen Pharma
EuroGen Pharmaceuticals Ltd
EuroGen Pharmaceuticals is a pharma organization headquartered in GB. Primary therapeutic focus areas include Spinal Cord Injury, Neurological; Disorder, Nervous System. NovaPharmaNews links 2 clinical program(s), 0 drug
Company details
- Status
- Public
- HQ
- Princeton, USA
- Founded
- 2004
- Employees
- 322
- Programs
- 2
- Drugs
- 5
- Patents
- 0
Stem Cell
Phase 1 · mab · Neurological; Disorder, Nervous System
Stem Cell for Neurological; Disorder, Nervous System is a Phase 1 program (mab) at EuroGen Pharmaceuticals Ltd with 1 ClinicalTrials.gov record(s).
Internal code NGBSI-16
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- EuroGen Pharmaceuticals Ltd
- Phase
- Phase 1
- Modality
- mab
- Indication
- Neurological; Disorder, Nervous System
- Status
- terminated
- Trials
- 1